Development

A lone researcher synthesizes a novel Alzheimer's compound in a garage lab

development2026-06-28

Claim

A lone PhD synthesized PAC-832, the first selective GalR1 antagonist for Alzheimer's, in a garage lab run by Claude Code and a liquid-handling robot.

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Knowledge graphopen in browser →

Reported in
Actor
Evidence for
Supersedes
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.